Häussinger D - Search Results

1

Hyperosmotic activation of the CD95 death receptor system.

Reinehr R, Häussinger D. Reinehr R, et al. Among authors: haussinger d. Acta Physiol (Oxf). 2006 May-Jun;187(1-2):199-203. doi: 10.1111/j.1748-1716.2006.01541.x. Acta Physiol (Oxf). 2006. PMID: 16734756 Review.

2

Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells.

Müschen M, Warskulat U, Douillard P, Gilbert E, Häussinger D. Müschen M, et al. Among authors: haussinger d. Hepatology. 1998 Jan;27(1):200-8. doi: 10.1002/hep.510270131. Hepatology. 1998. PMID: 9425938

3

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by interferon gamma and all-trans retinoic acid.

Müschen M, Warskulat U, Schmidt B, Schulz WA, Häussinger D. Müschen M, et al. Among authors: haussinger d. Biol Chem. 1998 Aug-Sep;379(8-9):1083-91. doi: 10.1515/bchm.1998.379.8-9.1083. Biol Chem. 1998. PMID: 9792441

4

Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1.

Reinehr RM, Kubitz R, Peters-Regehr T, Bode JG, Häussinger D. Reinehr RM, et al. Among authors: haussinger d. Hepatology. 1998 Dec;28(6):1566-77. doi: 10.1002/hep.510280617. Hepatology. 1998. PMID: 9828221

5

Release of osmolytes from perfused rat liver on perivascular nerve stimulation: alpha-adrenergic control of osmolyte efflux from parenchymal and nonparenchymal liver cells.

vom Dahl S, Bode JG, Reinehr RM, Mönnighoff I, Kubitz R, Häussinger D. vom Dahl S, et al. Among authors: haussinger d. Hepatology. 1999 Jan;29(1):195-204. doi: 10.1002/hep.510290114. Hepatology. 1999. PMID: 9862867

6

Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin.

Moers C, Warskulat U, Müschen M, Even J, Niederacher D, Josien R, Koldovsky U, Beckmann MW, Häussinger D. Moers C, et al. Among authors: haussinger d. Int J Cancer. 1999 Feb 9;80(4):564-72. doi: 10.1002/(sici)1097-0215(19990209)80:4<564::aid-ijc14>3.0.co;2-x. Int J Cancer. 1999. PMID: 9935158 Free article.

7

Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation.

Müschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Häussinger D. Müschen M, et al. Among authors: haussinger d. Gastroenterology. 1999 Mar;116(3):666-77. doi: 10.1016/s0016-5085(99)70189-7. Gastroenterology. 1999. PMID: 10029626

8

Involvement of soluble CD95 in Churg-Strauss syndrome.

Müschen M, Warskulat U, Perniok A, Even J, Moers C, Kismet B, Temizkan N, Simon D, Schneider M, Häussinger D. Müschen M, et al. Among authors: haussinger d. Am J Pathol. 1999 Sep;155(3):915-25. doi: 10.1016/S0002-9440(10)65191-7. Am J Pathol. 1999. PMID: 10487849 Free PMC article.

9

CD95 ligand expression in dedifferentiated breast cancer.

Müschen M, Moers C, Warskulat U, Niederacher D, Betz B, Even J, Lim A, Josien R, Beckmann MW, Häussinger D. Müschen M, et al. Among authors: haussinger d. J Pathol. 1999 Nov;189(3):378-86. doi: 10.1002/(SICI)1096-9896(199911)189:3<378::AID-PATH439>3.0.CO;2-D. J Pathol. 1999. PMID: 10547600

10

Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner.

Graf D, Kurz AK, Fischer R, Reinehr R, Häussinger D. Graf D, et al. Among authors: haussinger d. Gastroenterology. 2002 May;122(5):1411-27. doi: 10.1053/gast.2002.32976. Gastroenterology. 2002. PMID: 11984527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,107 results

Search Page